DaVita HealthCare Partners is trading 16% down at $191.50 after its latest quarterly update highlighted stagnant patient volumes and a lack of guidance upgrades.
- While the company beat Q2 expectations for revenue and EPS, it only reiterated its 2026 financial outlook rather than raising it.
- The sharp post-earnings selloff comes despite the broader market and healthcare sector trading higher today.